Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds

Respirology

Volumn 18, Issue 6, 2013, Pages 895-911

  Wagner, Darcy E ^b   Bonvillain, Ryan W ^a   Jensen, Todd ^c   Girard, Eric D ^d   Bunnell, Bruce A ^a   Finck, Christine M ^d   Hoffman, Andrew M ^e   Weiss, Daniel J ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d Farmington   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

decellularization; lung; recellularization; stem cells; tissue engineering

Indexed keywords

SCLEROPROTEIN; TISSUE SCAFFOLD;

BIOENGINEERING; CELL POPULATION; DECELLULARIZATION; EMBRYONIC STEM CELL; EX VIVO STUDY; EXTRACELLULAR MATRIX; FETUS CELL; HUMAN; IMMUNOGENICITY; IMPLANTATION; LUNG; LUNG ALVEOLUS EPITHELIUM; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCEDURES; REVIEW; SPECIES DIFFERENCE; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

DECELLULARIZATION; LUNG; RECELLULARIZATION; STEM CELLS; TISSUE ENGINEERING;

ANIMALS; BIOENGINEERING; HUMANS; LUNG; LUNG TRANSPLANTATION; MODELS, ANIMAL; STEM CELLS; TISSUE SCAFFOLDS;

EID: 84880815189     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12102     Document Type: Review

References (92)

1. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27: 397-412.
2. Eisner MD, Anthonisen N, Coultas D, et al. An official American thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 182: 693-718.
3. Badylak SF, Weiss DJ, Caplan A, et al. Engineered whole organs and complex tissues. Lancet 2012; 379: 943-952.
4. Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Trans. Int. 2011; 24: 223-232.
5. Wertheim JA, Baptista PM, Soto-Gutierrez A,. Cellular therapy and bioartificial approaches to liver replacement. Curr. Opin. Org. Trans. 2012; 17: 235-240.
6. Ott H, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008; 14: 213-221.
7. Krawiec JT, Vorp DA,. Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials 2012; 33: 3388-3400.
8. Totonelli G, et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials 2012; 33: 3401-3410.
9. Fishman JM, De Coppi P, Elliott MJ, et al. Airway tissue engineering. Exp. Opin. Biol. Ther. 2011; 11: 1623-1635.
10. Baiguera S, Del Gaudio C, Jaus MO, et al. Long-term changes to in vitro preserved bioengineered human trachea and their implications for decellularized tissues. Biomaterials 2012; 33: 3662-3672.
11. Haag J, Baiguera S, Jungebluth P, et al. Biomechanical and angiogenic properties of tissue-engineered rat trachea using genipin cross-linked decellularized tissue. Biomaterials 2012; 33: 780-789.
12. Haykal S, Soleas JP, Salna M, et al. Evaluation of the structural integrity and extracellular matrix components of tracheal allografts following cyclical decellularization techniques: comparison of three protocols. Tissue Eng. Part C: Methods 2012; 18: 614-623.
13. Hinderer S, Schesny M, Bayrak A, et al. Engineering of fibrillar decorin matrices for a tissue-engineered trachea. Biomaterials 2012; 33: 5259-5266.
14. Jungebluth P, Bader A, Baiguera S, et al. The concept of in vivo airway tissue engineering. Biomaterials 2012; 33: 4319-4326.
15. Jungebluth P, Moll G, Baiguera S, et al. Tissue-engineered airway: a regenerative solution. Clin. Pharmacol. Ther. 2012; 91: 81-93.
16. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng. 2006; 12: 717-728.
17. Lin YM, Boccaccini AR, Polak JM, et al. Biocompatibility of poly-DL-lactic acid (PDLLA) for lung tissue engineering. J. Biomater. Appl. 2006; 21: 109-118.
18. Cortiella J, Nichols JE, Kojima K, et al. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006; 12: 1213-1225.
19. Mondrinos MJ, Koutzaki S, Lelkes PI, et al. A tissue-engineered model of fetal distal lung tissue. Am. J. Physiol. Lung Cell Mol. Physiol. 2007; 293: L639-650.
20. Nichols JE, Cortiella JC,. Engineering of a complex organ progress toward development of a tissue-engineered lung. Proc. Am. Thorac. Soc. 2008; 5: 723-730.
21. Roomans GM,. Tissue engineering and the use of stem/progenitor cells for airway epithelium repair. Eur. Cells Mater. 2010; 19: 284-299.
22. Andrade CF, Wong AP, Waddell TK, et al. Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L510-518.
23. Ingenito EP, Sen E, Tsai LW, et al. Design and testing of biological scaffolds for delivering reparative cells to target sites in the lung. J. Tissue Eng. Regen. Med. 2010; 4: 259-272.
24. Miller C, George S, Niklason L,. Developing a tissue-engineered model of the human bronchiole. J. Tissue Eng. Regen. Med. 2010; 4: 619-627.
25. Tsunooka N, Hirayama S, Medin JA, et al. A novel tissue-engineered approach to problems of the postpneumonectomy space. Ann. Thorac. Surg. 2011; 91: 880-886.
26. Hoganson DM, Pryor HI II, Vacanti JP,. Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr. Res. 2008; 63: 520-526.
27. Mondrinos MJ, Koutzaki SH, Poblete HM, et al. In vivo pulmonary tissue engineering: contribution of donor-derived endothelial cells to construct vascularization. Tissue Eng. Part A 2008; 14: 361-368.
28. Finck CM, Weiss DJ,. Embryonic stem cells and repair of lung injury. Mol. Ther. 2010; 18: 460-461.
29. Kuttan R, Spall RD, Duhamel RC, et al. Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung 1981; 159: 333-345.
30. Lwebuga-Mukasa JS, Ingbar DH, et al. Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture. Exp. Cell Res. 1986; 162: 423-435.
31. Price AP, England KA, et al. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng. Part A 2010; 16: 2581-2591.
32. Petersen TH, et al. Tissue-engineered lungs for in vivo implantation. Science 2010; 329: 538-541.
33. Cortiella J, Niles J, Cantu A, et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng. Part A 2010; 16: 2565-2580.
34. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 2010; 16: 927-933.
35. Song JJ, Kim SS, et al. Enhanced in vivo function of bioartificial lungs in rats. Ann. Thorac. Surg. 2011; 92: 998-1006.
36. Shamis Y, Hasson E, et al. Organ-specific scaffolds for in vitro expansion, differentiation, and organization of primary lung cells. Tissue Eng. Part C Methods 2011; 17: 861-870.
37. Daly AB, Wallis JM, Borg ZD, et al. Initial binding and re-cellularization of de-cellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng. Part A 2012; 18: 1-16.
38. Wallis JM, Borg ZD, et al. Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng. Part C Methods 2012; 18: 420-432.
39. Bonvillain RW, Danchuk S, Sullivan DE, et al. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Eng. Part A 2012; 18: 2437-2452.
40. Longmire TA, Ikonomou L, et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 2012; 10: 398-411.
41. Jensen T, Roszell B, et al. A rapid lung de-cellularization protocol supports embryonic stem cell differentiation in vitro and following implantation. Tissue Eng. Part C Methods 2012; 18: 632-646.
42. Petersen TH, Calle EA, Colehour MB, et al. Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 2012; 195: 222-231.
43. Booth AJ, Hadley R, Cornett AM, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am. J. Respir. Crit. Care Med. 2012; 186: 866-876.
44. Bonenfant NR, Sokocevic D, et al. The effects of storage and sterilization on de-cellularized and re-cellularized whole lung. Biomaterials 2013; 34: 3231-3245.
45. Sokocevic D, Bonenfant NR, et al. The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs. Biomaterials 2013; 34: 3256-3269.
46. Petersen TH, Calle EA, Colehour MB, et al. Bioreactor for the long-term culture of lung tissue. Cell Transplant. 2011; 20: 1117-1126.
47. Ingenito EP, Tsai L, Murthy S, et al. Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Trans. 2012; 21: 175-189.
48. Rippon HJ, Polak JM, Qin M, et al. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 2006; 24: 1389-1398.
49. Lin YM, Zhang A, Rippon HJ, et al. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng. Part A 2010; 16: 1515-1526.
50. Fernandes H, Mentink A, Bank R, et al. Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. Tissue Eng. Part A 2010; 16: 1693-1702.
51. Mariani TJ, Sandefur S, Pierce RA,. Elastin in lung development. Exp. Lung Res. 1997; 23: 131-145.
52. Nguyen NM, Senior RM,. Laminin isoforms and lung development: all isoforms are not equal. Dev. Biol. 2006; 294: 271-279.
53. Weber DJ, Wilkes DS,. The role of autoimmunity in obliterative bronchiolitis after lung transplantation. Am. J. Physiol. Lung Cell Mol. Physiol. 2013; 304: L307-311.
54. Keane TJ, Londono R, Turner NJ, et al. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012; 33: 1771-1781.
55. Taylor KR, Gallo RL,. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006; 20: 9-22.
56. McQualter JL, Bertoncello I,. Concise review: deconstructing the lung to reveal its regenerative potential. Stem Cells 2012; 30: 811-816.
57. Weiss DJ, Bertoncello I, Borok Z, et al. Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 2011; 8: 223-272.
58. Lau AN, Goodwin M, Kim CF, et al. Stem cells and regenerative medicine in lung biology and diseases. Mol. Ther. J. Am. Soc. Gene Ther. 2012; 20: 1116-1130.
59. Murry CE, Keller G,. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008; 132: 661-680.
60. Roszell B, Mondrinos MJ, Seaton A, et al. Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng. Part A 2009; 15: 3351-3365.
61. Green MD, Chen A, Nostro MC, et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 2011; 29: 267-272.
62. Mou H, Zhao R, Sherwood R, et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 2012; 10: 385-397.
63. Samadikuchaksaraei A, Cohen S, Isaac K, et al. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng. 2006; 12: 867-875.
64. Wang D, Haviland DL, Burns AR, et al. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. U.S.A. 2007; 104: 4449-4454.
65. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
66. Sommer AG, Rozelle SS, Sullivan S, et al. Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector. J. Vis. Exp. 2012; 68: pii: 4327.
67. Wong AP, Bear CE, Chin S, et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat. Biotech. 2012; 30: 876-882.
68. Hong SG, Dunbar CE, Winkler T,. Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. Mol. Ther. 2013; 21: 272-281.
69. da Silva Meirelles L, Chagastelles PC, Nardi NB,. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006; 119: 2204-2213.
70. Lama VN, Smith L, Badri L, et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J. Clin. Invest. 2007; 117: 989-996.
71. Hoffman AM, Paxson JA, Mazan MR, et al. Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev. 2011; 10: 1719-1792.
72. Ingenito EP, Tsai L, Murthy S, et al. Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Trans. 2012; 21: 175-189.
73. Jun D, Garat C, West J, et al. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells 2011; 29: 725-735.
74. Gong X, Sun Z, Cui D, et al. Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells. Cell Biol. Int. 2012; DOI: 10.1042/CBI20120073.
75. Ingenito EP, Sen E, et al. Design and testing of biological scaffolds for delivering reparative cells to target sites in the lung. J. Tissue Eng. Regen. Med. 2010; 4: 259-272.
76. Wang G, Bunnell BA, Painter RG, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc. Natl Acad. Sci. U.S.A. 2005; 102: 186-191.
77. Sueblinvong V, Loi R, Eisenhauer PL, et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am. J. Respir. Crit. Care Med. 2008; 177: 701-711.
78. Loi R, Beckett T, Goncz KK, et al. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am. J. Respir. Crit. Care Med. 2006; 173: 171-179.
79. Kotton DN, Fabian AJ, Mulligan RC,. Failure of bone marrow to reconstitute lung epithelium. Am. J. Respir. Cell Mol. Biol. 2005; 33: 328-334.
80. Ding BS, Nolan DJ, et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011; 147: 539-553.
81. Volckaert T, Dill E, et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J. Clin. Invest. 2011; 121: 4409-4419.
82. Franz S, Rammelt S, Scharnweber D, et al. Immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011; 32: 6692-6709.
83. Badylak SF, Gilbert TW,. Immune response to biologic scaffold materials. Semin. Immunol. 2008; 20: 109-116.
84. Shaw AS, Filbert EL,. Scaffold proteins and immune-cell signalling. Nat. Rev. Immunol. 2009; 9: 47-56.
85. Daly KA, Liu S, Agrawal V, et al. Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling. Biomaterials 2012; 33: 91-101.
86. Brown BN, Valentin JE, Stewart-Akers AM, et al. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009; 30: 1482-1491.
87. Brown BN, Ratner BD, Goodman SB, et al. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012; 33: 3792-3802.
88. Brown BN, Londono R, Tottey S, et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater. 2012; 8: 978-987.
89. Sanchez-Esteban J, Tsai SW, Sang J, et al. Effects of mechanical forces on lung-specific gene expression. Am. J. Med. Sci. 1998; 316: 200-204.
90. Boudreault F, Tschumperlin DJ,. Stretch-induced mitogen-activated protein kinase activation in lung fibroblasts is independent of receptor tyrosine kinases. Am. J. Respir. Cell Mol. Biol. 2010; 43: 64-73.
91. Huang Z, Wang Y, Nayak PS, et al. Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions. J. Biol. Chem. 2012; 287: 18091-18102.
92. Weibel ER,. It takes more than cells to make a good lung. Am. J. Respir. Crit. Care Med. 2013; 187: 342-346.